BTIG keeps a Buy rating on Mersana Therapeutics (MRSN) with a $6 price target after the company presented data for Emi-Le from the Phase I ...

BTIG analyst Mark Massaro lowered the firm’s price target on NeoGenomics (NEO) to $18 from $21 and keeps a Buy rating on the shares. The stock ...

Fintel reports that on January 10, 2025, BTIG initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy recommendation.

DHT Holdings Inc (DHT) stock saw a modest uptick, ending the day at $10.71 which represents a slight increase of $0.66 or 6.57% from the prior close of $10.05. The stock opened at $10.59 and touched a ...

FREYR Battery Inc (FREY) stock saw a decline, ending the day at $2.35 which represents a decrease of $-0.25 or -9.62% from the prior close of $2.6. The stock opened at $2.52 and touched a low of $2.32 ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they will ...

BTIG Chief Market Technician Jonathan Krinsky thinks the market can “continue to make upside progress” into year-end and sees a new all-time high for the S&P 500 (SPX) above 6,100. However ...

Last week, BTIG analyst Jake Fuller reiterated a Buy rating on Uber Technologies (UBER) stock with a price target of $90. The analyst remains bullish on the ride-hailing company but expects its Q4 ...

The S&P 500's rally of 1.8% over just the last two sessions is nice, "but not a game changer yet," according to BTIG's technical guru, Jonathan Krinsky. The chart he provides, below, shows the stock ...

BTIG's Krinsky noted that while equity markets in the first half of 2024 were fueled mostly by the surge in mega-cap names ...

According to a BTIG strategist, the rally in the index was rejected from the previous support trendline and even though there are still four days left for the Santa Claus rally to deliver gains, there ...